10 results on '"B, Castan"'
Search Results
2. Guidelines for the management of accidental exposure to Brucella in a country with no case of brucellosis in ruminant animals.
- Author
-
Stahl JP, Bru JP, Gehanno JF, Herrmann JL, Castan B, Deffontaines G, Sotto A, Lepelletier D, Tattevin P, Godefroy N, Haddad E, Mailles A, and Lavigne JP
- Subjects
- Animals, Brucellosis veterinary, Humans, Practice Guidelines as Topic, Ruminants, Brucellosis diagnosis, Brucellosis drug therapy
- Published
- 2020
- Full Text
- View/download PDF
3. Impact of the French Infectious Diseases Society's (SPILF) proposals for shorter antibiotic therapies.
- Author
-
Macheda G, Luc A, Béraud G, Castan B, Gauzit R, Lesprit P, Tattevin P, Thilly N, and Pulcini C
- Subjects
- Adult, Antimicrobial Stewardship methods, Drug Administration Schedule, Female, France epidemiology, Humans, Infections drug therapy, Infections epidemiology, Infectious Disease Medicine organization & administration, Male, Middle Aged, Online Systems, Practice Patterns, Physicians' standards, Societies, Medical organization & administration, Surveys and Questionnaires, Anti-Bacterial Agents administration & dosage, Antimicrobial Stewardship standards, Guideline Adherence statistics & numerical data, Infectious Disease Medicine standards, Practice Guidelines as Topic, Practice Patterns, Physicians' statistics & numerical data, Societies, Medical standards
- Abstract
Objective: To compare the practices of French infection specialists related to antibiotic therapy duration between 2016 and 2018., Methods: We conducted two identical surveys (in 2016 and 2018) targeting hospital-based infection specialists (medical physicians, pharmacists) who gave at least weekly advice on antibiotic prescriptions. The questionnaire included 15 clinical vignettes. Part A asked about the durations of antibiotic therapies they would usually advise to prescribers, and part B asked about the shortest duration they would be willing to advise for the same clinical situations., Results: We included 325 specialists (165 in 2016 and 160 in 2018), mostly infectious disease specialists (82.4%, 268/325), members of antibiotic stewardship teams in 72% (234/325) of cases. Shorter antibiotic treatments (as compared with the literature) were advised to prescribers in more than half of the vignettes by 71% (105/147) of respondents in 2018, versus 46% (69/150) in 2016 (P<0.001). Guidelines used by participants displayed fixed durations for 77% (123/160) of cases in 2018 versus 21% (35/165) in 2016. Almost all respondents (89%, 131/160) declared they were aware of the 2017 SPILF's proposal., Conclusion: The release of guidelines promoting shorter durations of antibiotic therapy seems to have had a favourable impact on practices of specialists giving advice on antibiotic prescriptions., (Copyright © 2019 Elsevier Masson SAS. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
4. [Antibiotic stewardship: A 2017 update].
- Author
-
Castan B, Lesprit P, Alfandari S, Bonnet E, Diamantis S, Gauzit R, Kerneis S, Leroy J, Lescure X, Meyssonnier V, Mondain V, Pavese P, Rabaud C, Stahl JP, Tattevin P, Roblot F, and Pulcini C
- Subjects
- France, Humans, Antimicrobial Stewardship organization & administration, Antimicrobial Stewardship standards
- Published
- 2017
- Full Text
- View/download PDF
5. Proposal for shorter antibiotic therapies.
- Author
-
Wintenberger C, Guery B, Bonnet E, Castan B, Cohen R, Diamantis S, Lesprit P, Maulin L, Péan Y, Peju E, Piroth L, Stahl JP, Strady C, Varon E, Vuotto F, and Gauzit R
- Subjects
- Drug Utilization statistics & numerical data, Humans, Practice Guidelines as Topic, Time Factors, Anti-Bacterial Agents administration & dosage, Bacterial Infections drug therapy
- Abstract
Objectives: Reducing antibiotic consumption has now become a major public health priority. Reducing treatment duration is one of the means to achieve this objective. Guidelines on the therapeutic management of the most frequent infections recommend ranges of treatment duration in the ratio of one to two. The Recommendation Group of the French Infectious Diseases Society (SPILF) was asked to collect literature data to then recommend the shortest treatment durations possible for various infections., Methods: Analysis of the literature focused on guidelines published in French and English, supported by a systematic search on PubMed. Articles dating from one year before the guidelines publication to August 31, 2015 were searched on the website., Results: The shortest treatment durations based on the relevant clinical data were suggested for upper and lower respiratory tract infections, central venous catheter-related and uncomplicated primary bacteremia, infective endocarditis, bacterial meningitis, intra-abdominal, urinary tract, upper reproductive tract, bone and joint, skin and soft tissue infections, and febrile neutropenia. Details of analyzed articles were shown in tables., Conclusion: This work stresses the need for new well-conducted studies evaluating treatment durations for some common infections. Following the above-mentioned work focusing on existing literature data, the Recommendation Group of the SPILF suggests specific study proposals., (Copyright © 2017 Elsevier Masson SAS. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
6. [Antibiotic stewardship: What's new?]
- Author
-
Castan B, Lesprit P, Alfandari S, Bonnet E, Diamantis S, Gauzit R, Kernéis S, Leroy J, Lescure FX, Mondain V, Pavese P, Rabaud C, Stahl JP, Tattevin P, Roblot F, and Pulcini C
- Subjects
- Antimicrobial Stewardship standards, France, International Cooperation, Practice Guidelines as Topic, Societies, Medical, Antimicrobial Stewardship trends
- Published
- 2016
- Full Text
- View/download PDF
7. Management of non-necrotizing cellulitis in France.
- Author
-
Lemaire X, Bonnet E, Castan B, Forestier E, Lescure FX, Roblot F, and Pulcini C
- Subjects
- Administration, Oral, Ambulatory Care, Anti-Bacterial Agents administration & dosage, Cellulitis complications, Comorbidity, Disease Management, Disease Progression, Drug Administration Schedule, France, Health Care Surveys, Hospitalization, Humans, Hyperalgesia etiology, Infusions, Intravenous, Practice Guidelines as Topic, Practice Patterns, Physicians' statistics & numerical data, Sepsis drug therapy, Sepsis etiology, Anti-Bacterial Agents therapeutic use, Cellulitis drug therapy
- Abstract
Objective: We aimed to assess medical practices of French infectious disease specialists or any other relevant physicians related to the management of non-necrotizing cellulitis (NNC)., Methods: We sent an online questionnaire to members of the French Infectious Diseases Society (SPILF) mailing list in September 2015., Results: A total of 108 specialists took part in the survey and 10% (11/107) declared to always admit NNC patients to hospital. As for the others, 18% declared to admit patients in more than 80% of cases, 49% in 50-80% of cases, 26% in 20-50% of cases, and 7% in less than 20% of cases. The most frequent criteria for hospital admission were severe sepsis/septic shock (99%), poor social conditions (99%), rapid extension of skin lesions (93%), high level of pain (86%), and failure of first-line antibiotic therapy (84%). Participants mentioned similar criteria for reasons to initiate the intravenous (IV) antibiotic therapy. Fifty-three percent of respondents declared initiating antibiotic therapy using the IV route in more than 80% of cases. Physicians declared that the usual antibiotic therapy duration were <7 days (6%), 8-10 days (57%), 11-14 days (34%), and >15 days (3%)., Conclusion: Criteria for hospital admission and use of the IV route for antibiotic therapy as well as optimal treatment duration in patients presenting with NNC need to be detailed in guidelines and evaluated in prospective studies., (Copyright © 2016 Elsevier Masson SAS. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
8. [European Antibiotic Awareness Day: What is new in France?].
- Author
-
Pulcini C, Alfandari S, Ballereau F, Bonnet E, Bruneel F, Castan B, Chidiac C, Cohen R, Descamps D, Doco-Lecompte T, Gauzit R, Guéry B, Jarlier V, Lesprit P, Marcelin AG, Molina JM, Rabaud C, Riché A, Salmon-Céron D, Senneville E, Stahl JP, Tattevin P, Varon E, and Roblot F
- Subjects
- Anniversaries and Special Events, France, Humans, Anti-Bacterial Agents therapeutic use, Drug Resistance, Bacterial, Health Education
- Published
- 2015
- Full Text
- View/download PDF
9. Mycobacterium marinum infection following contact with reptiles: vivarium granuloma.
- Author
-
Bouricha M, Castan B, Duchene-Parisi E, and Drancourt M
- Subjects
- Animals, Anti-Bacterial Agents therapeutic use, Clarithromycin therapeutic use, Gentamicins therapeutic use, Humans, Male, Mycobacterium Infections, Nontuberculous drug therapy, Mycobacterium Infections, Nontuberculous microbiology, Mycobacterium Infections, Nontuberculous transmission, Mycobacterium marinum drug effects, Mycobacterium marinum pathogenicity, Mycobacterium marinum physiology, Skin microbiology, Skin Diseases, Bacterial drug therapy, Skin Diseases, Bacterial microbiology, Skin Diseases, Bacterial transmission, Young Adult, Mycobacterium Infections, Nontuberculous diagnosis, Mycobacterium marinum isolation & purification, Reptiles microbiology, Skin Diseases, Bacterial diagnosis
- Abstract
A 19-year-old man presented with a 1.5-cm nodule on the first dorsal metacarpal ray. The patient denied having contact with fish tanks or fish, but recalled handling many reptiles without gloves in the vivarium where he worked. A culture of a skin biopsy specimen yielded Mycobacterium marinum. The clinical outcome was favourable after a 2-week course of intramuscular gentamicin (180 mg daily) combined with a 6-week course of oral clarithromycin (500 mg twice a day). Doctors should be aware that vivariums, in addition to fish tanks, can be sources of M. marinum exposure., (Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
10. [Rhodococcus equi pulmonary abscess in HIV infection].
- Author
-
About I, Castan B, Capdeville J, and Vanche J
- Subjects
- Actinomycetales Infections drug therapy, Actinomycetales Infections microbiology, Adult, Anti-Bacterial Agents therapeutic use, Humans, Lung Abscess drug therapy, Lung Abscess microbiology, Male, AIDS-Related Opportunistic Infections drug therapy, AIDS-Related Opportunistic Infections microbiology, Actinomycetales Infections etiology, Lung Abscess etiology, Rhodococcus equi
- Abstract
RE is a well-known Gram positive bacillus which is usually pathogenic in animals. Disease in humans is rare, but incidence has clearly increased with the advent of AIDS. In humans, RE predominantly infect people with impaired cellular immunity so that it is considered an opportunistic agent. Its must common manifestation in immuno-compromised patients is a slowly progressive pneumonia which may cavitate. Even with early diagnostic and optimal and prolonged antibiotic therapy, the mortality of RE, infections remain high (20 to 55%). Problems in clinical and therapic management are illustrated in our two cases of cavitated pneumonia in two AIDS patients.
- Published
- 1996
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.